Target intelligence / Profile preview

Ion channel or membrane transporter

Molecular classification
Ion channel, Transporter, Transmembrane protein, Enzyme (for ATPase-containing pumps), Carrier protein
01

Overview

Ion channels and membrane transporters are two classes of transmembrane proteins essential for the controlled movement of ions and small molecules across cell membranes. Ion channels form selective pores that permit rapid, passive flux of ions such as sodium, potassium, calcium, and chloride down their electrochemical gradients. They are tightly regulated and important for processes such as neuronal excitability, muscle contraction, and secretory functions. Membrane transporters, in contrast, use energy-dependent or energy-independent mechanisms to move ions and a variety of substrates across membranes; they include active pumps (e.g., ATPases), secondary active transporters (symporters, antiporters), and facilitators of diffusion. Both channels and transporters are implicated in major diseases (including neurological, cardiovascular, renal, metabolic, and cancer), making them prominent drug targets. The classification "Ion channels and membrane transporters" is not a specific molecular entity but rather a superfamily or a functional category comprising hundreds of distinct gene products with specialized roles, highlighting the need for more precise molecular nomenclature in drug discovery and biomedical research[1][2][4][5][6][9][10]. Note: The target "Ion channels and membrane transporters" refers to a large group or category, not a single molecular target. For structured data purposes, more specific protein names (e.g., "Voltage-gated sodium channel subunit alpha") should be used for particular entries.

Other names
Ion channelsMembrane transportersIon pumpsIon carrier proteinsChannel proteinsTransmembrane ion transportersPumpsCarriers
02

Mechanism of action

Inhibition of ion flux (channel blockers); Activation or opening of channels (agonists/openers); Blockade of substrate transport (transporter inhibitors); Modulation of channel gating (allosteric modulators); Reversal of gradient (pumps modulated to change ion direction); Inhibition of ATPase activity (for energy-dependent transporters)

03

Biological functions

Electrochemical signalingSignal transductionRegulation of membrane potentialCellular excitabilityCell volume regulationNutrient uptakeWaste and toxin removalMaintenance of homeostasis
04

Disease associations

Neurological diseases (e.g., epilepsy, channelopathies)Cardiovascular diseases (e.g., arrhythmias)Cancer (e.g., drug resistance via efflux pumps)Diabetes (e.g., insulin secretion regulation)InflammationRenal and hepatic diseasesOther (various inherited and acquired disorders)
05

Safety considerations

Off-target effects due to the wide physiological role of many channels and transportersCardiotoxicity (long QT syndrome from channel inhibitors)Neurological side effects (seizures, tremors)Electrolyte imbalance (hypokalemia, hyponatremia)Drug-drug interactions (due to transporter-mediated absorption or clearance)Drug resistance (especially in cancer, due to efflux transporters)
06

Interacting drugs

Ion channel blockers (e.g., calcium channel blockers, sodium channel blockers)

7 more in the full profile.

07

Biomarkers

Expression levels of specific ion channels or transportersGenetic mutations (e.g., channelopathies)Functional assays (e.g., patch clamp recordings)Drug resistance profiles (e.g., ABC transporter overexpression in tumors)

Beyond the preview

Go deeper on Ion channel or membrane transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ion channel or membrane transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call